This guideline outlines the Doxy-PEP Protocol for the prevention of certain sexually transmitted infections (STIs), specifically targeting syphilis, gonorrhea, and chlamydia, following potential exposure. It provides guidelines for healthcare providers on how to administer doxycycline as post-exposure prophylaxis (PEP), detailing protocols for prescription, timing, and patient education to reduce the risk of infection.

This webpage provides information on the transmission of sexually transmitted diseases (STDs) through kissing. It discusses the risk factors, including the presence of sores or infections, and offers advice on preventing the spread of STDs through oral contact. 

This webpage discusses whether cold sores are a form of herpes and their potential link to sexually transmitted diseases (STDs). It provides information on the causes of cold sores, their connection to the herpes simplex virus (HSV), and how HSV can be transmitted through sexual contact.

This webpage discusses the importance of routine testing for herpes, emphasizing its role in managing cold sores and preventing transmission. It highlights how herpes can be asymptomatic, making regular screening essential for early detection and management. The webpage also covers testing options and the benefits of early intervention.

This video explains HIV self-testing, a private and convenient way to check one’s HIV status in as little as 20 minutes. It highlights how to interpret test results and explores available prevention and treatment options to support early detection and care.

This journal discusses the development of educational animations aimed at increasing awareness and understanding of HIV pre-exposure prophylaxis (PrEP) for women. The study explores qualitative research on how these animations can effectively communicate PrEP’s benefits, addressing barriers to its use and promoting better health decision-making. The research emphasizes the potential of digital health interventions in improving HIV prevention and the role of tailored educational content for enhancing women’s engagement with PrEP.

This article highlights groundbreaking research on tuberculosis (TB) treatment, revealing why a key TB drug remains effective against resistant strains. Rutgers Health researchers uncover the molecular mechanisms that enable this drug to combat TB bacteria, potentially inspiring improved treatments and drug development strategies. The findings emphasize the need for continued research to address antibiotic resistance and enhance global TB control efforts.

This toolkit serves as a comprehensive resource for communities affected by tuberculosis. It offers practical tools and guidance to support TB advocacy, treatment, and care, with a focus on marginalized populations. It also provides strategies for addressing barriers to care, promoting patient-centered approaches, and advocating for policy changes to strengthen global TB prevention and control efforts.